Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (300)

« Back to Publications

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Li S. et al, (2026), Cell Rep Med

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

Li S. et al, (2026), iScience, 29

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Dorbutr T. et al, (2026), Sci Rep

Exploring the ethics of tuberculosis human challenge models.

Rohrig A. et al, (2026), J Med Ethics, 52, 251 - 260

Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Stewart I. et al, (2026), EBioMedicine, 124

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Korompis M. et al, (2026), Front Immunol, 17

Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition.

Tangie E. et al, (2025), Immunology, 176, 373 - 384

Evaluation of 1st WHO anti-malaria reference reagent for competition ELISA harmonisation and development of ADAMSEL analytical platform.

Khatri B. et al, (2025), Biologicals, 92

Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.

Chen C. et al, (2025), Chest, 168, 33 - 42

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Drennan PG. et al, (2025), Lancet Microbe, 6

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Roope LSJ. et al, (2025), Contemp Clin Trials Commun, 45

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Marshall JL. et al, (2025), Nat Commun, 16

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

Siegal EZ. et al, (2025), NPJ Vaccines, 10

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.

Tyrer F. et al, (2025), Diabetes Obes Metab, 27, 767 - 776

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Korompis M. et al, (2025), Sci Rep, 15

Load More

1
2
3
4
5
6
7
...
»